Patents by Inventor Martha Alicia De La Rosa

Martha Alicia De La Rosa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180298035
    Abstract: Provided are compounds of formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 18, 2018
    Inventors: Wieslaw Mieczyslaw KAZMIERSKI, Martha Alicia DE LA ROSA, Vicente SAMANO
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180290988
    Abstract: This invention is directed to photoluminescent compounds based on rhodamine dyes with green emission and uses thereof for photoluminescence based devices.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 11, 2018
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D. DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • Compounds and methods for treating HIV
    Patent number: 9163023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: October 20, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Lita Suwandi, David Temelkoff, Emile Velthuisen, Jason Gordon Weatherhead
  • COMPOUNDS AND METHODS FOR TREATING HIV
    Publication number: 20150191469
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: July 10, 2013
    Publication date: July 9, 2015
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Lita Suwandi, David Temelkoff, Emile Velthuisen, Jason Gordon Weatherhead
  • Isoquinoline compounds and methods for treating HIV
    Patent number: 9029391
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: May 12, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Simon Haydar, Brian Alvin Johns, Emile Johann Velthuisen
  • N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
    Patent number: 8993593
    Abstract: This invention provides a compound of formula A The compound provided herein can affect the opening of, or otherwise modulate, voltage-gated potassium channels. The compound provided herein is useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: March 31, 2015
    Assignee: Valeant Pharmaceuticals International
    Inventors: Jean-Michel Vernier, Martha Alicia De La Rosa, Huanming Chen, Jim Zhen Wu, Gary Lee Larson, Ian Wayne Cheney
  • Azaindole compounds and methods for treating HIV
    Patent number: 8609653
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: December 17, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Emile Johann Velthuisen, Jason Weatherhead, Vicente Samano
  • Isoquinoline Compounds And Methods For Treating HIV
    Publication number: 20130289027
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: January 23, 2012
    Publication date: October 31, 2013
    Applicant: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Simon Haydar, Brian Alvin Johns, Emile Johann Velthuisen
  • Azaindole Compounds and Methods for Treating HIV
    Publication number: 20130018049
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: July 12, 2012
    Publication date: January 17, 2013
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Emile Johann Velthuisen, Jason Weatherhead, Vicente Samano
  • Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
    Patent number: 8293911
    Abstract: This invention provides a compound of formula IA where X?O or S; Y is O or S; q=1 or 0; and other substituents are defined herein. Such compounds can affect the opening of, or otherwise modulate, voltage-gated potassium channels. They are potentially useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: October 23, 2012
    Assignee: Valeant Pharmaceuticals International
    Inventors: Jean-Michel Vernier, Martha Alicia De La Rosa, Huanming Chen, Jim Zhen Wu, Gary Lee Larson, Ian Wayne Cheney
  • DERIVATIVES OF 4-(N-AZACYCLOALKYL) ANILIDES AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20110003850
    Abstract: This invention provides a compound of formula IA where X=0 or S; Y is 0 or S; q=1 or 0; and other substituents are defined herein. Such compounds can affect the opening of, or otherwise modulate, voltage-gated potassium channels. Such compounds useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
    Type: Application
    Filed: February 1, 2010
    Publication date: January 6, 2011
    Applicant: Valeant Pharmaceuticals International, Inc.
    Inventors: Jean-Michel Vernier, Martha Alicia De La Rosa, Huanming Chen, Jim Zhen Wu, Gary Lee Larson, Ian Wayne Cheney
  • Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
    Publication number: 20080139610
    Abstract: This invention provides a compound of formula IA where X?O or S; Y is O or S; q=1 or 0; and other substituents are defined herein. Such compounds can affect the opening of, or otherwise modulate, voltage-gated potassium channels. They are potentially useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
    Type: Application
    Filed: August 22, 2007
    Publication date: June 12, 2008
    Applicant: Valeant Pharmaceuticals North America
    Inventors: Jean-Michel Vernier, Martha Alicia De La Rosa, Huanming Chen, Jim Zhen Wu, Gary Lee Larson, Ian Wayne Cheney
  • Derivatives of 1,3-diamino benzene as potassium channel modulators
    Publication number: 20080045534
    Abstract: This invention provides compounds of formula I where X?O or S; Y is O or S; q=1 or 0; and other substituents are defined herein. The invention also provides pharmaceutical compositions comprising compounds of formula I. Such compounds are potassium channel modulators.
    Type: Application
    Filed: August 16, 2007
    Publication date: February 21, 2008
    Applicant: Valeant Pharmaceuticals North America
    Inventors: Jean-Michel Vernier, Samedy Ouk, Martha Alicia De La Rosa, David Abraham Paisner